Design considerations in an active medical product safety monitoring system
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Design considerations in an active medical product safety monitoring system
Authors
Keywords
-
Journal
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
Volume 21, Issue -, Pages 32-40
Publisher
Wiley
Online
2012-01-19
DOI
10.1002/pds.2316
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Using high-dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance system
- (2012) Jeremy A. Rassen et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Antidepressants and Fracture Risk in Older Adults: A Comparative Safety Analysis
- (2011) J J Gagne et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Refilling and Switching of Antiepileptic Drugs and Seizure-Related Events
- (2010) J J Gagne et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Negative Controls
- (2010) Marc Lipsitch et al. EPIDEMIOLOGY
- Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study
- (2010) Catherine B. Johannes et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Instrumental variable methods in comparative safety and effectiveness research
- (2010) M. Alan Brookhart et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- A basic study design for expedited safety signal evaluation based on electronic healthcare data
- (2010) Sebastian Schneeweiss PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Use of a claims-based active drug safety surveillance system to assess the risk of acute pancreatitis with exenatide or sitagliptin compared to metformin or glyburide
- (2009) David D. Dore et al. CURRENT MEDICAL RESEARCH AND OPINION
- High-dimensional Propensity Score Adjustment in Studies of Treatment Effects Using Health Care Claims Data
- (2009) Sebastian Schneeweiss et al. EPIDEMIOLOGY
- Illustrating bias due to conditioning on a collider
- (2009) Stephen R Cole et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Managing Drug-Risk Information — What to Do with All Those New Numbers
- (2009) Jerry Avorn et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antipsychotic Agents and Sudden Cardiac Death — How Should We Manage the Risk?
- (2009) Sebastian Schneeweiss et al. NEW ENGLAND JOURNAL OF MEDICINE
- Signal detection for vaccine side effects that have not been specified in advance
- (2009) Alexander M. Walker PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Aprotinin and the risk of death and renal dysfunction in patients undergoing cardiac surgery: a meta-analysis of epidemiologic studies
- (2009) Joshua J. Gagne et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Confounder summary scores when comparing the effects of multiple drug exposures
- (2009) Suzanne M. Cadarette et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Observational Studies Analyzed Like Randomized Experiments
- (2008) Miguel A. Hernán et al. EPIDEMIOLOGY
- Aprotinin during Coronary-Artery Bypass Grafting and Risk of Death
- (2008) Sebastian Schneeweiss et al. NEW ENGLAND JOURNAL OF MEDICINE
- Supplementary data collection with case-cohort analysis to address potential confounding in a cohort study of thromboembolism in oral contraceptive initiators matched on claims-based propensity scores
- (2008) P. Mona Eng et al. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY
- Comparison of epidemiologic methods for active surveillance of vaccine safety
- (2008) David L. McClure et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started